The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of perioperative and neoadjuvant therapies in gastric and gastroesophageal (GEJ) adenocarcinoma (AC): A network meta-analysis.
 
Muhammad Umair Anjum
No Relationships to Disclose
 
Syed Arsalan Ahmed Naqvi
No Relationships to Disclose
 
Salman Ayub Jajja
No Relationships to Disclose
 
Ammad Raina
No Relationships to Disclose
 
Muhammad Umar Afzal
No Relationships to Disclose
 
Kunwer Sufyan Faisal
No Relationships to Disclose
 
Diana Segovia
Employment - Mayo Clinic
 
Zhaohui Jin
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Lilly (Inst)
 
Harry Yoon
Consulting or Advisory Role - Amgen (Inst); Astellas Scientific and Medical Affairs Inc; Astellas Scientific and Medical Affairs Inc; AstraZeneca; AstraZeneca (Inst); beigene; BeiGene (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology; Jazz Pharmaceuticals (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); Zymeworks (Inst)
Research Funding - Amgen (Inst); BeiGene (Inst); Bristol Myers Squibb Foundation (Inst); CARsgen Therapeutics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - beigene
 
Pedro Uson Junior
No Relationships to Disclose
 
Jason Starr
Consulting or Advisory Role - Exelixis
Research Funding - Amgen (Inst); Aminex (Inst); Arcus Biosciences (Inst); Camurus (Inst); RayzeBio (Inst); Viewpoint Molecular Targeting (Inst)
 
Daniel Ahn
Stock and Other Ownership Interests - Natera
Consulting or Advisory Role - Advanced Accelerator Applications; Daiichi Sankyo/Astra Zeneca; Eisai; Exelixis; Genentech/Roche; Incyte; Incyte; Novartis
Research Funding - AstraZeneca; Bayer
 
Tanios Bekaii-Saab
Consulting or Advisory Role - Abbvie; Amgen (Inst); Arcus Biosciences (Inst); AstraZeneca; Bayer (Inst); BeiGene; Boehringer Ingelheim; Caladrius Biosciences; Caladrius Biosciences; Celularity; Daiichi Sankyo/UCB Japan; Deciphera; Eisai; Eisai; Exact Sciences; Foundation Medicine; Foundation Medicine; Illumina; Immuneering; Incyte (Inst); Ipsen (Inst); Janssen; Kanaph Therapeutics; Lilly (Inst); Natera; Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SOBI; Stemline Therapeutics; Treos Bio; Zai Lab
Patents, Royalties, Other Intellectual Property - Patent WO/2018/183488; Patent WO/2019/055687
Other Relationship - 1Globe Health Institute; AstraZeneca; Exelixis; FibroGen; Imugene; Lilly; Merck (Inst); Pancreatic Cancer Action Network; Replimune; Sun Biopharma; Suzhou Kintor Pharmaceuticals; UpToDate; Xilis
 
Irbaz Riaz
Honoraria - OncLive/MJH Life Sciences; Oncotarget
Research Funding - ASCO
 
Mohamad Sonbol
Honoraria - Novartis
Research Funding - Lilly (Inst); Taiho Oncology (Inst)